OVAGEN

This tripeptide emerged from Vladimir Khavinson's bioregulator research program, specifically targeting liver and digestive tract tissues. Laboratory studies have focused on its potential to support hepatocyte function and maintain the integrity of gastrointestinal mucosa. Researchers investigating liver regeneration and gut barrier dysfunction have shown particular interest in its cellular signaling properties.

The peptide appears to interact directly with DNA in liver and intestinal cells, potentially influencing the transcription of genes involved in tissue repair and metabolic processes. Think of it as a molecular switch that may help cells remember how to function properly—particularly hepatocytes responsible for detoxification and GI epithelial cells that form the gut barrier. This gene-level influence could theoretically restore normal cellular behavior in damaged or aging tissues.